StoneX Maintains Buy on Agilon Health, Raises Price Target to $145
Benzinga Newsdesk 1 hour ago
Analyst RatingsNewsPrice Target
StoneX analyst Bill Sutherland maintains Agilon Health (NYSE:AGL) with a Buy and raises the price target from $140 to $145.
StoneX analyst Bill Sutherland maintains Agilon Health (NYSE:AGL) with a Buy and raises the price target from $140 to $145.